Literature DB >> 31400406

Exosomes derived from liver cancer cells reprogram biological behaviors of LO2 cells by transferring Linc-ROR.

Xiaoqin He1, JiaJun Yu2, Lin Xiong1, Yuanshi Liu1, Li Fan1, Yue Li1, Biao Chen1, Jiayu Chen1, XiMing Xu3.   

Abstract

OBJECTIVE: Exosomes have been described as a messenger between cells' communication and contain various information (lipids, proteins, mRNAs, microRNAs, LncRNAs). It has been proved that Linc-ROR was enriched in exosomes released by HepG2 cells. Our aim was to investigate whether exosomes released by HepG2 cells could affect the biological behaviors of LO2 cells and whether Linc-ROR played an important role in this process.
METHODS: Exosomes-derived from HepG2 cells were isolated and characterized. Real-time PCR assessed expression level of Linc-ROR in specimens of cancerous tissues and carcinoma-adjacent tissues. The Linc-ROR expression level in HepG2, Huh7, SMMC-7721, Bel-7402, LO2 cells and exosomes was detected by real-time PCR. Knockdown the expression of Linc-ROR in HepG2 by using effective siRNA. Cell counting method was used to test LO2 cells proliferative activities. Flow cytometry was performed to quantify the apoptosis rates of LO2 cells cocultured with exosomes. The expression levels of OCT4, NANOG, SOX2, P53 and CD133 were assessed by western blot.
RESULTS: Linc-ROR was enriched in exosomes released by HepG2 cells. Exosomes derived from HepG2 cells promoted the proliferation and suppressed the apoptosis of LO2 cells suffering nutrient deficiency. Knockdown the expression of Linc-ROR in HepG2 or LO2 cells could significantly impaired the exosomes' effects on LO2 cells. In addition, the long-term coculture with exosomes would obviously change the biological behaviors of LO2 cells.
CONCLUSIONS: Our experiments indicated the HepG2 cells could transfer its Linc-ROR to the LO2 cells via exosomes, then influenced the recipient cells.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Apoptosis; Exosomes; LO2; Linc-ROR; Liver cancer; Proliferation

Mesh:

Substances:

Year:  2019        PMID: 31400406     DOI: 10.1016/j.gene.2019.144044

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

Review 1.  Emerging role of exosomes in cancer progression and tumor microenvironment remodeling.

Authors:  Mahshid Deldar Abad Paskeh; Maliheh Entezari; Sepideh Mirzaei; Amirhossein Zabolian; Hossein Saleki; Mohamad Javad Naghdi; Sina Sabet; Mohammad Amin Khoshbakht; Mehrdad Hashemi; Kiavash Hushmandi; Gautam Sethi; Ali Zarrabi; Alan Prem Kumar; Shing Cheng Tan; Marios Papadakis; Athanasios Alexiou; Md Asiful Islam; Ebrahim Mostafavi; Milad Ashrafizadeh
Journal:  J Hematol Oncol       Date:  2022-06-28       Impact factor: 23.168

Review 2.  Exosomes as therapeutic vehicles in liver diseases.

Authors:  Jingyi Ding; Ju Wang; Jiajia Chen
Journal:  Ann Transl Med       Date:  2021-04

3.  Downregulated Expression of linc-ROR in Gastric Cancer and Its Potential Diagnostic and Prognosis Value.

Authors:  Xiuchong Yu; Haixiang Ding; Yijiu Shi; Liangwei Yang; Jiaming Zhou; Zhilong Yan; Bingxiu Xiao
Journal:  Dis Markers       Date:  2020-10-24       Impact factor: 3.434

4.  Long intergenic noncoding RNA smad7 (Linc-smad7) promotes the epithelial-mesenchymal transition of HCC by targeting the miR-125b/SIRT6 axis.

Authors:  Lili Han; Lijun Jia; Ying Zan
Journal:  Cancer Med       Date:  2020-10-10       Impact factor: 4.452

5.  Hsa‑circRNA‑G004213 promotes cisplatin sensitivity by regulating miR‑513b‑5p/PRPF39 in liver cancer.

Authors:  Ling Qin; Zibo Zhan; Chunxue Wei; Xuemei Li; Tongqin Zhang; Jun Li
Journal:  Mol Med Rep       Date:  2021-04-13       Impact factor: 2.952

Review 6.  Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma.

Authors:  Haoming Xia; Ziyue Huang; Shuqiang Liu; Xudong Zhao; Risheng He; Zhongrui Wang; Wenguang Shi; Wangming Chen; Zhizhou Li; Liang Yu; Peng Huang; Pengcheng Kang; Zhilei Su; Yi Xu; Judy Wai Ping Yam; Yunfu Cui
Journal:  Front Oncol       Date:  2021-03-26       Impact factor: 6.244

Review 7.  Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases.

Authors:  Lauren A Newman; Kate Muller; Andrew Rowland
Journal:  Cell Mol Life Sci       Date:  2022-04-10       Impact factor: 9.261

8.  Long non-coding ROR promotes the progression of papillary thyroid carcinoma through regulation of the TESC/ALDH1A1/TUBB3/PTEN axis.

Authors:  Yuxia Fan; Xin Fan; Hao Yan; Zheng Liu; Xiaoming Wang; Qingling Yuan; Jie Xie; Xiubo Lu; Yang Yang
Journal:  Cell Death Dis       Date:  2022-02-16       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.